<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gluconeogenesis is increased in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and contributes significantly to fasting and <z:hpo ids='HP_0011998'>postprandial hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We recently reported the discovery of the first potent and selective inhibitors of <z:chebi fb="15" ids="28757">fructose</z:chebi> 1,6-bisphosphatase (FBPase), a rate-controlling enzyme of gluconeogenesis </plain></SENT>
<SENT sid="2" pm="."><plain>Herein we describe <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> effects of the lead inhibitor, MB06322 (CS-917), in <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In fasting male ZDF rats with overt <z:mp ids='MP_0002055'>diabetes</z:mp>, a single dose of MB06322 inhibited gluconeogenesis by 70% and overall endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production by 46%, leading to a reduction in blood <z:chebi fb="105" ids="17234">glucose</z:chebi> of &gt;200 mg/dl </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> treatment of freely feeding 6-week-old male <z:chebi fb="3" ids="16646">Zucker</z:chebi> diabetic fatty (ZDF) rats delayed the development of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and preserved pancreatic function </plain></SENT>
<SENT sid="5" pm="."><plain>Elevation of <z:chebi fb="4" ids="24996">lactate</z:chebi> ( approximately 1.5-fold) occurred after 4 weeks of treatment, as did the apparent shunting of precursors into <z:chebi fb="4" ids="17855">triglycerides</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Profound <z:chebi fb="105" ids="17234">glucose</z:chebi> lowering ( approximately 44%) and similar metabolic ramifications were associated with 2-week intervention therapy of 10-week-old male ZDF rats </plain></SENT>
<SENT sid="7" pm="."><plain>In high-fat diet-fed female ZDF rats, MB06322 treatment for 2 weeks fully attenuated <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> without evidence of metabolic perturbation other than a modest reduction in <z:chebi fb="15" ids="28087">glycogen</z:chebi> stores ( approximately 20%) </plain></SENT>
<SENT sid="8" pm="."><plain>The studies confirm that excessive gluconeogenesis plays an integral role in the pathophysiology of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and suggest that FBPase inhibitors may provide a future treatment option </plain></SENT>
</text></document>